Clene, Inc. (CLNN)
4.435
+0.12
(+2.66%)
USD |
NASDAQ |
Aug 24, 16:00
4.435
0.00 (0.00%)
After-Hours: 20:00
Clene Total Assets (Quarterly) : 23.04M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.04M |
| March 31, 2026 | 21.66M |
| December 31, 2025 | 18.13M |
| September 30, 2025 | 22.31M |
| June 30, 2025 | 22.12M |
| March 31, 2025 | 25.31M |
| December 31, 2024 | 27.34M |
| September 30, 2024 | 31.57M |
| June 30, 2024 | 40.33M |
| March 31, 2024 | 45.07M |
| December 31, 2023 | 52.34M |
| September 30, 2023 | 60.43M |
| June 30, 2023 | 67.84M |
| March 31, 2023 | 39.89M |
| December 31, 2022 | 44.49M |
| September 30, 2022 | 36.00M |
| June 30, 2022 | 44.54M |
| Date | Value |
|---|---|
| March 31, 2022 | 53.36M |
| December 31, 2021 | 63.06M |
| September 30, 2021 | 73.04M |
| June 30, 2021 | 73.28M |
| March 31, 2021 | 58.53M |
| December 31, 2020 | 68.24M |
| September 30, 2020 | 26.12M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 48.78M |
| September 30, 2019 | 48.15M |
| June 30, 2019 | 47.47M |
| March 31, 2019 | 47.32M |
| December 31, 2018 | 47.16M |
| September 30, 2018 | 46.95M |
| June 30, 2018 | 0.2157M |
| March 31, 2018 | 0.1714M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0647M |
| Brainstorm Cell Therapeutics, Inc. | 0.788M |
| Summit Therapeutics, Inc. | 752.18M |
| Kezar Life Sciences, Inc. | 68.00M |
| Protara Therapeutics, Inc. | 176.09M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 47.82M |
| Shareholders Equity (Quarterly) | -24.78M |
| Debt to Equity Ratio | -0.9018 |
| Current Ratio | 3.074 |
| Net Debt Paydown Yield | -0.36% |